Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 50.47M | £ 24.83M | £ 71.22M | £ 81.57M | £ 49.38M |
Total Assets | £ 978.85M | £ 1.14B | £ 1.02B | £ 1.02B | £ 1.00B |
Total Debt | £ 252.70M | £ 403.56M | £ 344.07M | £ 344.27M | £ 362.42M |
Net Debt | £ 202.23M | £ 378.73M | £ 272.86M | £ 262.70M | £ 313.04M |
Total Liabilities | £ 286.16M | £ 448.09M | £ 401.78M | £ 412.86M | £ 421.07M |
Stockholders Equity | £ 692.70M | £ 687.04M | £ 622.58M | £ 608.16M | £ 579.23M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |